TC
BSTC

TFS Capital’s BioSpecifics Technologies Corp. BSTC Stock Holding History

TFS Capital’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-18,208
Closed -$901K – 481
2017
Q2 		$901K Buy
18,208
+2,480
+16% +$130K 0.35% 69
2017
Q1 		$862K Sell
15,728
-17,145
-52% -$908K 0.28% 120
2016
Q4 		$1.83M Sell
32,873
-7,596
-19% -$365K 0.49% 7
2016
Q3 		$1.85M Sell
40,469
-11,920
-23% -$479K 0.44% 22
2016
Q2 		$2.09M Sell
52,389
-2,116
-4% -$77.5K 0.38% 12
2016
Q1 		$1.9M Sell
54,505
-30,601
-36% -$1.12M 0.27% 80
2015
Q4 		$3.66M Buy
85,106
+8,876
+12% +$445K 0.39% 56
2015
Q3 		$3.32M Buy
76,230
+15,177
+25% +$819K 0.32% 71
2015
Q2 		$3.15M Sell
61,053
-7,498
-11% -$320K 0.31% 71
2015
Q1 		$2.68M Sell
68,551
-45,201
-40% -$1.77M 0.26% 86
2014
Q4 		$4.39M Buy
113,752
+34,030
+43% +$1.3M 0.42% 31
2014
Q3 		$2.81M Buy
79,722
+6,108
+8% +$179K 0.24% 107
2014
Q2 		$1.99M Buy
73,614
+30,177
+69% +$786K 0.16% 187
2014
Q1 		$1.13M Buy
+43,437
New +$1.04M 0.07% 403

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

TFS Capital's BSTC Position: Q3 2017 in Review

TFS Capital sold out of BioSpecifics Technologies Corp. (BSTC) in Q3 2017, closing a stake of 18,208 shares — an estimated $901K sold.

TFS Capital first reported a position in BSTC in Q1 2014 and held it in 14 quarters. The position peaked at $4.39M in Q4 2014. 87 funds tracked by Wall St. Rank hold BSTC as of Q3 2017.

  • TFS Capital reported no remaining BioSpecifics Technologies Corp. position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 18,208 BioSpecifics Technologies Corp. shares in Q3 2017, an estimated $901K.
  • TFS Capital first reported a position in BioSpecifics Technologies Corp. in Q1 2014 and held it in 14 quarters.
  • TFS Capital's BioSpecifics Technologies Corp. position peaked at $4.39M in Q4 2014.
  • 87 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.